Israel Englander My Md Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.22 - $0.58 $4,239 - $11,177
19,271 Added 44.98%
62,116 $16,000
Q2 2023

Aug 14, 2023
BUY
$1.44 - $2.26 $61,696 - $96,829
42,845 New
42,845 $64,000
Q4 2022

Feb 14, 2023
BUY
$0.92 - $96.0 $49,772 - $5.19 Million
54,101 Added 380.7%
68,312 $79,000
Q3 2022

Nov 14, 2022
BUY
$2.22 - $82.2 $31,548 - $1.17 Million
14,211 New
14,211 $37,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email